INNOVATIVE GLOBAL HEALTH SOLUTIONS LTDActive

Company number 13677540Private limited companyIncorporated 2021

Key figures

£2,401,546+15.1%
Net assets 2024/25
+100.0%
Average annual growth 2021/22–2024/25
01 m2 m3 m2021/222022/232023/242024/25

INNOVATIVE GLOBAL HEALTH SOLUTIONS LTD does not disclose its turnover in its latest accounts; the profit for the year is as stated in the accounts.

Ratios

2024/25
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
01 m2 m3 m2021/222022/232023/242024/25
Filed accounts2021/22–2024/25
2021/222022/232023/242024/25
Profit for the year———494,208
Cash at bank and in hand—379,280——
Total assets301,0001,759,3602,089,5022,417,453
Total liabilities6007511,95215,036
Net assets / total equity300,4001,758,6092,086,7392,401,546
Average number of employees0000

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: INNOVATIVE GLOBAL HEALTH SOLUTIONS LTD

Company

INNOVATIVE GLOBAL HEALTH SOLUTIONS LTD is a private limited company registered with Companies House under company number 13677540. It was incorporated on 13 Oct 2021. Its status is active. The registered office is in Chandler's ford (SO53). Its nature of business (SIC 2007) is research and experimental development on social sciences and humanities (72200).

Accounts

The latest accounts in the database are for 2024/25 (period ending 31 Aug 2025); the company files micro-entity accounts. Profit for the year was £494,208. Net assets were £2,401,546, up 15.1% on the previous year. Total assets were £2,417,453 and total liabilities £15,036. The company had an average of 0 employees. Figures are available for 4 financial years (2021/22–2024/25).

Control and charges

The company has 2 current directors. 2 persons with significant control are registered.

Filing deadlines

The next accounts are due by 31 May 2027. The next confirmation statement is due by 15 Mar 2027.